Thanks Parto I think you recall correctly at +5. I had conservatively assumed +2 per 6 month data point but certainly not that this could have been factored into the data. You would think they would need to state this on the graph if it was - not that labelling is their strong point.
Performance seems highly understated but I appreciate they have to follow a protocol on claims .
Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-64
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.49M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $17.46K | 2.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 4501358 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2830688 | 15 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |